Merck sued Azurity Pharmaceuticals Inc. on May 3 in Delaware District Court over patent infringement claims. The court action, brought by McCarter & English and Williams & Connolly, asserts a ...

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. March 20, 2025 at 12:00 AM. Email. Share. Print. Case Digest Summary. Defendants appealed the ruling affirming United States Patent and ...

VGX-3100: Inovio Pharmaceuticals. ... Merck sharp & Dohme Key Products. VGX-3100 Artesunate ABI-2280 GX-188E Pembrolizumab ...

Pharmaceutical company, Merck is closing a Pennsylvania plant. Cherokee Pharmaceuticals, a wholly owned subsidiary of Merck ...

A Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan ...

Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced ... which is bioequivalent and therapeutically equivalent to STROMECTOL ® Tablets of Merck Sharp and Dohme LLC in ...

Merck Sharp & Dohme LLC and Otsuka Pharmaceutical Co. Ltd. have patented cellular tumor antigen p53 (TP53) (Y220C mutant) activators reported to be useful for the treatment of cancer.

Cherokee Pharmaceuticals, a wholly owned subsidiary of Merck Sharp & Dohme, which is a wholly owned subsidiary of Merck & Co., has filed a Worker Adjustment and Retraining Notification with the ...